在急性淋巴细胞白血病治疗期间,儿童何时以及为什么会患上高血糖症?
Lívia Cristina Oliveira E Silva1, Adriana Aparecida Siviero-Miachon1,2, Ana Virgínia Lopes Sousa2
1Universidade Federal de São Paulo, Escola Paulista de Medicina, Division of Pediatric Endocrinology - São Paulo (SP), Brazil.
概括
在化疗期间,急性淋巴细胞白血病 (ALL) 的儿童中,高血糖是常见的,特别是在青春期患者中. 然而,这种常见的副作用并没有恶化他们的结果,包括感染或死亡率.
科学领域:
- 儿科瘤学 儿科瘤学
- 内分泌学 在内分泌学.
- 血液学 血液学 血液学
背景情况:
- 高血糖是癌症治疗过程中已知的并发症.
- 了解其风险因素和影响对于儿科急性淋巴细胞白血病 (ALL) 管理至关重要.
研究的目的:
- 在接受化疗的儿科ALL患者中确定高血糖症的危险因素.
- 评估高血糖症对治疗结果的影响.
主要方法:
- 188名儿科ALL患者 (2004-2017年) 的回顾性队列研究.
- 在诱导和巩固化疗阶段评估的高血糖症.
- 多变量分析检查了与患者/疾病特征和结果 (感染,复发,死亡率) 的关联.
主要成果:
- 高血糖症发生在43.6%的患者中,主要发生在诱导期间.
- 青春期状态,年龄较小和复发风险较高与高血糖风险增加有关 (青春期:风险约为8倍).
- 高血糖症与感染,复发或死亡率的增加无关;然而,超重/肥胖和胰腺炎/复发性感染与较高的死亡率相关.
结论:
- 高血糖是儿科ALL治疗中常见的早期不良事件,特别是在青春期和高风险患者中.
- 尽管高发病率,高血糖并没有对这一队列的临床结果产生负面影响.
- 在密集治疗阶段,早期识别和监测高血糖是很重要的.
相关概念视频
Hypoglycemia and Glucagon
826
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
826
Insulin: Dosing Regimen and Adverse Effects
677
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
677
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion
209
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Disorders of Leukocytes
1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K


